Envarsus XR 1 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DX25FVDCL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,884
Award facts
- Contract value 100% obligated
- $3,883.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on March 12, 2025, for the supply of Envarsus XR 1 mg tablets (30-count packages) with a ceiling value of $3,883.50. This firm fixed-price delivery order, which must be completed by April 2, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. The contract falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in supplying medications, vaccines, medical devices, and healthcare commodities to military and veteran healthcare systems. The company's federal contract portfolio demonstrates consistent capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains. As a prime contractor under the DLA Troop Support Medical IDC, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Envarsus XR, an immunosuppressant medication used in transplant patients, exemplifies the company's role in supplying specialized pharmaceutical products essential to federal healthcare operations.
Quick answers
Who was awarded contract SPE2DX25FVDCL?
SPE2DX25FVDCL was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on March 12, 2025.
How much is contract SPE2DX25FVDCL worth?
The government has obligated $3,884 on SPE2DX25FVDCL.
Is contract SPE2DX25FVDCL an order under another contract?
Yes. SPE2DX25FVDCL is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVDCL competed?
The extent of competition for SPE2DX25FVDCL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award